Ignite Creation Date:
2024-05-06 @ 2:05 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04213898
Status:
UNKNOWN
Last Update Posted:
2019-12-30
First Post:
2019-12-27
Brief Title:
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer
Sponsor:
Organization:
Henan Cancer Hospital